Defibrotide (DF) is effective in the treatment of severe veno-occlusive disease (VOD) and multi-system organ failure (MOF) post stem cell transplantation (SCT): Results of a phase II, multicenter, randomized study.
Richardson, P; Soiffer, RJ; Antin, JH; Jin, Z; Vredenburgh, JJ; Kurtzberg, J; Martin, PL; Hockenbery, D; Steinbach, G; Murray, KF; Vogelsang, GB; Chen, A; Krishnan, A; Prasad, VK; Warren, DL; Momtaz, P; Batchelder, A; Wei, LJ; Rifai, N; Bradwin, G; Iacobelli, M; McDonald, GB; Guinan, EC
Volume / Issue
Start / End Page
International Standard Serial Number (ISSN)
45th Annual Meeting of the American-Society-of-Hematology
Conference Start Date
Conference End Date